dosing schedule retatrutide Schedule: Proven 2026 Guide Retatrutide Dose Escalation Chart &

The SURMOUNT-2 trial (2023) focused specifically on patients with type 2 diabetes and obesity, demonstrating average weight loss of 14.7% at the 15 mg dose, a substantial improvement over prior GLP-1 monotherapy results in this population

The bacteria and organisms living INSIDE you affect your overall health and wellness, including your metabolic health and weight

Reference photos help us understand your aesthetic preferences

It is to recognize mild effects, reduce avoidable triggers, and know when medical review is appropriate

Serious but less common risks include pancreatitis, gallbladder disease (gallstones, cholecystitis), kidney injury from dehydration if vomiting or diarrhea is severe, and allergic reactions

You do not need a prescription label on the pen itself, but carrying your pharmacy label or a letter from your prescriber can speed things up if a TSA agent has questions